Hydrolyzed collagen for use in reducing blood glucose
AssigneeRousselot B.V.
InventorsKristof Robert CALLEMIN, Elien Monique GEVAERT, Arne GOES, Janne PRAWITT, Sara VLEMINCKX
Life of this patent
Estimating the term…
Abstract
The present invention relates to a hydrolyzed collagen formulation for use in decreasing blood glucose. The hydrolyzed collagen is obtained by enzymatic hydrolysis of a collagen-containing material with a combination of enzymes comprising two or more enzymes selected from the group consisting of a neutral protease, a carboxypeptidase, and an aminopeptidase. The hydrolyzed collagen formulation is particularly suitable as a food supplement, such as for use in ameliorating hyperglycemia and/or a risk factor hyperglycemia.
Claims29
Hydrolyzed collagen for use in ameliorating hyperglycemia or a risk factor for hyperglycemia, wherein the hydrolyzed collagen is obtained by enzymatic hydrolysis of a collagen-containing material with a combination of enzymes comprising a neutral protease and one or both of a carboxypeptidase, and an aminopeptidase.
6-9. (canceled)
(canceled)
(canceled)
Method for obtaining hydrolyzed collagen, comprising:
- a) providing a collagen-containing material in a liquid formulation;
- and
- b) subjecting the collagen-containing material to a combination of enzymes comprising a neutral protease and one or both of a carboxypeptidase, and an aminopeptidase, optionally wherein the combination of enzymes comprises a neutral protease, a carboxypeptidase, and an aminopeptidase.
(canceled)
(canceled)
21-22. (canceled)
24-25. (canceled)
27-32. (canceled)
Hydrolyzed collagen,
- wherein the hydrolyzed collagen:
- has a weight average molecular weight of 2000-5000 Da, preferably 2500-4500 Da;
- and
- comprises 35-60% by weight of collagen peptides with a molecular weight in the range of 2000-5000 Da, calculated on total weight of collagen peptides in the hydrolyzed collagen.
38-39. (canceled)
Dependencies are inferred from the claim text.